Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
allotted, authoritative, baseline, bid, consummate, consummated, contrast, delisted, delisting, dissolution, finite, group, passage, Plant, reclassified, regain, signal, split, sublease, subleased, thereunder, thirty, undiscounted, vi, winding
Removed:
affiliate, antagonist, chemotherapeutic, CIHL, component, convert, de, discovering, dosing, durect, element, exclusively, execution, formulated, hair, half, identification, improved, IncuMed, IND, injection, INSERM, Institut, intense, intratympanic, jointly, la, led, location, managerial, motivate, moved, NaN, NeuroSystec, neurotrophic, NMDA, Note, otoprotection, people, periodically, persistent, physical, President, receptor, Recherche, remedy, repair, routinely, Sant, selective, technical, tiered, tumor, utilizing
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view